Llew Keltner - Net Worth and Insider Trading

Llew Keltner Net Worth

The estimated net worth of Llew Keltner is at least $60,255 dollars as of 2024-03-28. Llew Keltner is the Director of Raptor Pharmaceutical Corp and owns about 6,695 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $60,255. Details can be seen in Llew Keltner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Llew Keltner has not made any transactions after 2015-07-01 and currently still holds the listed stock(s).

Transaction Summary of Llew Keltner

To

Llew Keltner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Llew Keltner owns 2 companies in total, including Raptor Pharmaceutical Corp () , and MannKind Corp () .

Click here to see the complete history of Llew Keltner’s form 4 insider trades.

Insider Ownership Summary of Llew Keltner

Ticker Comapny Transaction Date Type of Owner
Raptor Pharmaceutical Corp 2016-10-24 director
MannKind Corp 2004-07-28 director

Llew Keltner Latest Holdings Summary

Llew Keltner currently owns a total of 1 stock. Llew Keltner owns 6,695 shares of Raptor Pharmaceutical Corp (RPTP) as of July 1, 2015, with a value of $60,255.

Latest Holdings of Llew Keltner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RPTP Raptor Pharmaceutical Corp 2015-07-01 6,695 9.00 60,255

Holding Weightings of Llew Keltner


Llew Keltner Form 4 Trading Tracker

According to the SEC Form 4 filings, Llew Keltner has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the sale of 50,000 shares on July 1, 2015, which brought Llew Keltner around $802,500.

Insider Trading History of Llew Keltner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Llew Keltner Trading Performance

GuruFocus tracks the stock performance after each of Llew Keltner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Llew Keltner is 34.72%. GuruFocus also compares Llew Keltner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Llew Keltner within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Llew Keltner's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Llew Keltner

Average Relative Return

50.49%

Average relative return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 41.2 34.72 17.6 50.49 -18.95
Relative Return to S&P 500(%) 39.29 30.57 10.11 40.93 -23.42

Llew Keltner Ownership Network

Ownership Network List of Llew Keltner

No Data

Ownership Network Relation of Llew Keltner


Llew Keltner Owned Company Details

What does Raptor Pharmaceutical Corp do?

Who are the key executives at Raptor Pharmaceutical Corp?

Llew Keltner is the director of Raptor Pharmaceutical Corp. Other key executives at Raptor Pharmaceutical Corp include Chief Medical Officer Krishna R Polu , Chief Financial Officer Michael P Smith , and Chief Commercial Officer David Happel .

Raptor Pharmaceutical Corp () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Raptor Pharmaceutical Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Raptor Pharmaceutical Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Raptor Pharmaceutical Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Raptor Pharmaceutical Corp Insider Transactions

No Available Data

Llew Keltner Mailing Address

Above is the net worth, insider trading, and ownership report for Llew Keltner. You might contact Llew Keltner via mailing address: 7 Hamilton Landing, Suite 100, Novato Ca 94949.

Discussions on Llew Keltner

No discussions yet.